Disease-modifying therapies for nonrelapsing multiple sclerosis: Costs and benefits of medical intervention

about

Disease-modifying therapies for nonrelapsing multiple sclerosis: Costs and benefits of medical intervention

Item

http://www.wikidata.org/entity/Q56882349

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 2013

@uk

name

Disease-modifying therapies fo ...... nefits of medical intervention

@en

Disease-modifying therapies fo ...... nefits of medical intervention

@nl

type

Item

label

Disease-modifying therapies fo ...... nefits of medical intervention

@en

Disease-modifying therapies fo ...... nefits of medical intervention

@nl

prefLabel

Disease-modifying therapies fo ...... nefits of medical intervention

@en

Disease-modifying therapies fo ...... nefits of medical intervention

@nl

P1476

Disease-modifying therapies fo ...... nefits of medical intervention

@en

P2093

David E Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Interferon beta for secondary progressive multiple sclerosis

Glatiramer acetate for multiple sclerosis

Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis

The American Academy of Neurology's top five choosing wisely recommendations.

Progressive multiple sclerosis.

P304

510-514

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/01.CPJ.0000436214.18755.AF

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30107016

http://www.w3.org/2001/XMLSchema#string

P932

6082358

http://www.w3.org/2001/XMLSchema#string